open access

Vol 10, Supp. G (2014)
suplement
Published online: 2015-03-20
Get Citation

EGFR mutated (exon 21) metastatic lung adenocarcinoma in female patient treated with erlotinib — case report

Krzysztof Leśniewski-Kmak

open access

Vol 10, Supp. G (2014)
suplement
Published online: 2015-03-20

Abstract

We present the case of advanced lung cancer female patients after histological and molecular diagnostic procedures, treated with EGFR tyrosine kinase inhibitor, erlotinib.

Abstract

We present the case of advanced lung cancer female patients after histological and molecular diagnostic procedures, treated with EGFR tyrosine kinase inhibitor, erlotinib.
Get Citation

Keywords

case report, non-small lung cancer, erlotinib

About this article
Title

EGFR mutated (exon 21) metastatic lung adenocarcinoma in female patient treated with erlotinib — case report

Journal

Oncology in Clinical Practice

Issue

Vol 10, Supp. G (2014)

Pages

9-10

Published online

2015-03-20

Keywords

case report
non-small lung cancer
erlotinib

Authors

Krzysztof Leśniewski-Kmak

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl